Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Infection-Fighting Cancer Treatment Could Boost Leukemia Risk


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Amenorrhea
Amniocentesis
Amniocentesis and CVS
More...

Related Healthscout Videos
 border=
Zapping Vocal Tumors
Keep Away Ovarian Cancer
Breakthrough for Fatal Lung Disease
Preventing Breast Cancer
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Detrol LA
Diflucan
Ditropan XL
More...

Related News Articles
 border=
Stars Don Red to Raise Awareness of Women's Heart Risk
Health Tip: Soothing Engorged Breasts
Sorafenib Slows Growth of Some Leukemias
Pregnant Women With Asthma Should Stay on Low Dose of Meds
More...


Page:  << Prev | 1 | 2

Typically, these mutated cells would simply die off. But growth factors may actually save these cells and allow them to grow into a cancer such as AML, Hershman explained. Or, the growth factors may lead to MDS, the bone marrow problem.

Cancer patients typically receive growth factors because they boost levels of infection-fighting white blood cells. Chemo destroys these infection-fighting cells, and the body can't quickly replace them.

But, Hershman said, questions remain. It's not certain that the growth factors actually caused the AML or MDS, she said. "It might be that people may be more susceptible to developing leukemia if they were more sensitive to the chemo," she said. "The chemo itself could have caused the leukemia."

Text Continues Below



The association is certainly "worthy of more research," said Dr. Len Lichtenfeld, deputy chief medical officer of the American Cancer Society.

Right now, however, the results "are a not an indication to change the standard of care," he said.

"Your doctor should tell you [growth factors] could cause difficulty later on," Lichtenfeld said. But doctors should also point out that "growth factor drugs have changed the face of cancer chemotherapy," he added. It's also important to note that the study only looked at women aged 65 and older, Lichtenfeld said.

Before these compounds were routinely given, he said, many patients had to be hospitalized as a result of reactions to chemotherapy, or their chemotherapy had to be delayed until they felt better.

Growth factors have been tied in the past to increased risks in breast cancer patients, Lichtenfeld said, but up until now, there was no data to support that suspicion. Hershman's study now provides some proof of a link, he said.

In an editorial accompanying the study, experts form Erasmus University Medical Center Rotterdam in the Netherlands point out that the benefits of chemo may far outweigh any risk of a second cancer.

More information

To learn more about the side effects of chemotherapy, visit the American Cancer Society.

Page:  << Prev | 1 | 2

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 2/7/2007

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





New Features

New ADHD Site!

SOURCES: Len Lichtenfeld, M.D., deputy chief medical officer, American Cancer Society, Atlanta; Dawn Hershman, M.D., M.S., assistant professor, medicine and epidemiology, Columbia University Medical Center, New York City; Feb. 7, 2007, Journal of the National Cancer Institute


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map